Merck & Co. (MRK)
(Delayed Data from NYSE)
$126.94 USD
+1.16 (0.92%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $126.98 +0.04 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Sales: Oncology: Keytruda
- 25,011.00
- 20,937.00
- 17,186.00
- 14,380.00
- 11,084.00
- Revenue - Line of Business (LOBR)
- Sales: Alliance Revenue: Lynparza
- 1,199.00
- 1,116.00
- 989.00
- 725.00
- 444.00
- Revenue - Line of Business (LOBR)
- Sales: Alliance revenue: Lenvima
- 960.00
- 876.00
- 704.00
- 580.00
- 404.00
- Revenue - Line of Business (LOBR)
- Sales: Oncology: Alliance revenue: Reblozyl
- 212.00
- 166.00
- 17.00
- --
- --
- Revenue - Line of Business (LOBR)
- Sales: Vaccines: Gardasil
- 8,886.00
- 6,897.00
- 5,673.00
- 3,938.00
- 3,737.00
- Revenue - Line of Business (LOBR)
- Sales: Vaccines: ProQuar/M-M-R II/Varivax
- 2,368.00
- 2,241.00
- 2,135.00
- 1,878.00
- 2,275.00
- Revenue - Line of Business (LOBR)
- Sales: RotaTeq
- 769.00
- 783.00
- 807.00
- 797.00
- 791.00
- Revenue - Line of Business (LOBR)
- Sales: Vaccines: Pneumovax
- 412.00
- 602.00
- 893.00
- 1,087.00
- 926.00
- Revenue - Line of Business (LOBR)
- Sales: Vaccines: Vaqta
- 180.00
- 173.00
- 179.00
- 170.00
- 238.00
- Revenue - Line of Business (LOBR)
- Total Vaccines
- 13,654.00
- 10,696.00
- 10,132.00
- 8,257.00
- 8,368.00
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Bridion
- 1,842.00
- 1,685.00
- 1,532.00
- 1,198.00
- 1,131.00
- Revenue - Line of Business (LOBR)
- Sales: Diabetes: Other Pharmaceutical
- 2,283.00
- 2,249.00
- 2,118.00
- 2,312.00
- 696.00
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Prevymis
- 605.00
- 428.00
- 370.00
- 281.00
- 165.00
- Revenue - Line of Business (LOBR)
- Sales: Cardiovascular: Alliance revenue - Adempas
- 367.00
- 341.00
- 342.00
- 281.00
- 204.00
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Zerbaxa
- 218.00
- 169.00
- -1.00
- 130.00
- 121.00
- Revenue - Line of Business (LOBR)
- Sales: Animal Health: Companion Animal
- 2,288.00
- 2,250.00
- 2,273.00
- 1,764.00
- 1,609.00
- Revenue - Line of Business (LOBR)
- Sales: Animal Health: Livestock
- 3,337.00
- 3,300.00
- 3,295.00
- 2,939.00
- 2,784.00
- Revenue - Line of Business (LOBR)
- Sales: Neuroscience: Belsomra - International
- 150.00
- 179.00
- 241.00
- 247.00
- 214.00
- Revenue - Line of Business (LOBR)
- Sales: Neuroscience: Belsomra - U.S.
- 81.00
- 79.00
- 78.00
- 81.00
- 92.00
- Revenue - Line of Business (LOBR)
- Sales: Virology: Isentress
- 483.00
- 633.00
- 769.00
- 857.00
- 975.00
- Revenue - Line of Business (LOBR)
- Sales: Diabetes: Janumet
- 1,177.00
- 1,700.00
- 1,964.00
- 1,971.00
- 2,041.00
- Revenue - Line of Business (LOBR)
- Sales: Diabetes: Januvia
- 2,189.00
- 2,813.00
- 3,324.00
- 3,306.00
- 3,482.00
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Noxafil
- 213.00
- 238.00
- 259.00
- 329.00
- 662.00
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Primaxin
- 213.00
- 239.00
- 259.00
- 251.00
- 273.00
- Revenue - Line of Business (LOBR)
- Sales: Immunology: Remicade
- 187.00
- 207.00
- 299.00
- 330.00
- 411.00
- Revenue - Line of Business (LOBR)
- Sales: Immunology: Simponi
- 710.00
- 706.00
- 825.00
- 838.00
- 830.00
- Revenue - Line of Business (LOBR)
- Segment revenues: Animal health
- 5,625.00
- 5,550.00
- 5,568.00
- 4,703.00
- 4,393.00
- Revenue - Line of Business (LOBR)
- Sales: Cardiovascular: Adempas
- 255.00
- 238.00
- 252.00
- 220.00
- 215.00
- Revenue - Line of Business (LOBR)
- Other Revenues
- 907.00
- 1,728.00
- 382.00
- 182.00
- 521.00
- Revenue - Line of Business (LOBR)
- Segment revenues: Pharmaceutical
- 53,583.00
- 52,005.00
- 42,754.00
- 36,610.00
- 41,751.00
- Revenue - Line of Business (LOBR)
- Sales: Vaccines: Vaxneuvance
- 665.00
- 170.00
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Sales: Hospital Acute Care: Dificid
- 302.00
- 263.00
- 175.00
- --
- --
- Revenue - Line of Business (LOBR)
- Sales: Virology: Lagevrio
- 1,428.00
- 5,684.00
- 952.00
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Oncology: Keytruda - U.S.
- 15,114.00
- 12,686.00
- 9,765.00
- 8,352.00
- 6,305.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Keytruda - International
- 9,897.00
- 8,251.00
- 7,421.00
- 6,028.00
- 4,779.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Lynparza - U.S.
- 607.00
- 584.00
- 515.00
- 417.00
- 269.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Lynparza - International
- 592.00
- 532.00
- 473.00
- 308.00
- 176.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Lenvima - U.S.
- 657.00
- 579.00
- 417.00
- 359.00
- 239.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Lenvima - International
- 303.00
- 297.00
- 287.00
- 220.00
- 165.00
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Reblozyl - U.S.
- 168.00
- 123.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Oncology: Alliance revenue: Reblozyl - International
- 43.00
- 43.00
- 17.00
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Gardasil - U.S.
- 2,083.00
- 2,065.00
- 1,881.00
- 1,755.00
- 1,831.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Gardasil - International
- 6,803.00
- 4,832.00
- 3,792.00
- 2,184.00
- 1,905.00
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Januvia - International
- 1,039.00
- 1,565.00
- 1,920.00
- 1,836.00
- 1,758.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Primaxin - International
- 211.00
- 238.00
- 258.00
- 248.00
- 271.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: ProQuar/M-M-R II - International
- 531.00
- 518.00
- 506.00
- 500.00
- 592.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Rotateq - International
- 276.00
- 275.00
- 334.00
- 311.00
- 284.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Noxafil - U.S.
- 32.00
- 51.00
- 60.00
- 42.00
- 282.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Noxafil - International
- 181.00
- 187.00
- 199.00
- 287.00
- 380.00
- Revenue - Geographic (GEOR)
- Sales: Primaxin - U.S.
- 1.00
- 1.00
- 2.00
- 2.00
- 2.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: ProQuad, M-M-R II and Varivax - U.S.
- 1,837.00
- 1,724.00
- 1,629.00
- 1,378.00
- 1,683.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: RotaTeq - U.S.
- 493.00
- 508.00
- 473.00
- 486.00
- 506.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Pneumovax - U.S.
- 127.00
- 346.00
- 547.00
- 727.00
- 679.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Pneumovax - International
- 285.00
- 256.00
- 346.00
- 359.00
- 247.00
- Revenue - Geographic (GEOR)
- Sales: Virology: Isentress - U.S.
- 215.00
- 274.00
- 294.00
- 326.00
- 398.00
- Revenue - Geographic (GEOR)
- Sales: Animal health - U.S.
- 1,804.00
- 1,822.00
- 1,758.00
- 1,484.00
- 1,306.00
- Revenue - Geographic (GEOR)
- Sales: Animal health - International
- 3,821.00
- 3,728.00
- 3,810.00
- 3,219.00
- 3,086.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Bridion - International
- 686.00
- 762.00
- 770.00
- 615.00
- 598.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Prevymis - International
- 341.00
- 240.00
- 218.00
- 162.00
- 81.00
- Revenue - Geographic (GEOR)
- Sales: Virology: Lagevrio - International
- 1,418.00
- 4,161.00
- 320.00
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Dificid - U.S.
- 274.00
- 241.00
- 166.00
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Dificid - International
- 28.00
- 22.00
- 10.00
- --
- --
- Revenue - Geographic (GEOR)
- Segment revenues: Pharmaceutical - U.S.
- 26,539.00
- 24,989.00
- 20,401.00
- 18,010.00
- --
- Revenue - Geographic (GEOR)
- Segment revenues: Pharmaceutical - International
- 27,044.00
- 27,016.00
- 22,353.00
- 18,600.00
- --
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Other pharmaceutical - U.S.
- 688.00
- 969.00
- 841.00
- 984.00
- --
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Other pharmaceutical: International
- 1,596.00
- 1,282.00
- 1,275.00
- 1,328.00
- --
- Revenue - Geographic (GEOR)
- Product sales: Other revenues - U.S.
- 137.00
- 395.00
- 266.00
- 71.00
- --
- Revenue - Geographic (GEOR)
- Product sales: Other revenues - International
- 770.00
- 1,333.00
- 116.00
- 111.00
- --
- Revenue - Geographic (GEOR)
- Geographic Revenue: International
- 31,635.00
- 32,077.00
- 26,279.00
- 21,930.00
- --
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Vaxneuvance - U.S.
- 561.00
- 163.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Vaxneuvance - International
- 103.00
- 7.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Geographic Revenue: United States
- 28,480.00
- 27,206.00
- 22,425.00
- 19,588.00
- 20,519.00
- Revenue - Geographic (GEOR)
- Sales: Virology: Isentress - International
- 268.00
- 359.00
- 474.00
- 326.00
- 576.00
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Janumet - International
- 954.00
- 1,344.00
- 1,597.00
- 1,494.00
- 1,452.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Bridion - U.S.
- 1,156.00
- 922.00
- 762.00
- 583.00
- 533.00
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Januvia - U.S.
- 1,151.00
- 1,248.00
- 1,404.00
- 1,470.00
- 1,724.00
- Revenue - Geographic (GEOR)
- Sales: Diabetes: Janumet - U.S.
- 223.00
- 355.00
- 367.00
- 477.00
- 589.00
- Revenue - Geographic (GEOR)
- Sales: Cardiovascular: Adempas - International
- 255.00
- 238.00
- 252.00
- 220.00
- 215.00
- Revenue - Geographic (GEOR)
- Sales: Neuroscience: Belsomra
- 231.00
- 258.00
- 318.00
- 327.00
- 306.00
- Revenue - Geographic (GEOR)
- Sales: Animal Health: Livestock - U.S.
- 700.00
- 710.00
- 667.00
- 612.00
- 582.00
- Revenue - Geographic (GEOR)
- Sales: Animal Health: Livestock - International
- 2,637.00
- 2,590.00
- 2,628.00
- 2,327.00
- 2,201.00
- Revenue - Geographic (GEOR)
- Sales: Animal Health: Companion Animal - U.S.
- 1,104.00
- 1,112.00
- 1,091.00
- 872.00
- 724.00
- Revenue - Geographic (GEOR)
- Sales: Animal Health: Companion Animal - International
- 1,184.00
- 1,138.00
- 1,182.00
- 892.00
- 885.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Vaqta - U.S.
- 119.00
- 95.00
- 100.00
- 103.00
- 130.00
- Revenue - Geographic (GEOR)
- Sales: Vaccines: Vaqta - International
- 61.00
- 78.00
- 79.00
- 67.00
- 108.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Zerbaxa - U.S.
- 119.00
- 89.00
- 4.00
- 74.00
- 63.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Zerbaxa - International
- 100.00
- 79.00
- -5.00
- 56.00
- 58.00
- Revenue - Geographic (GEOR)
- Sales: Cardiovascular: Alliance revenue: Adempas - U.S.
- 350.00
- 329.00
- 312.00
- 259.00
- 194.00
- Revenue - Geographic (GEOR)
- Sales: Cardiovascular: Alliance revenue: Adempas-International
- 16.00
- 12.00
- 30.00
- 22.00
- 10.00
- Revenue - Geographic (GEOR)
- Sales: Hospital Acute Care: Prevymis - U.S.
- 264.00
- 188.00
- 153.00
- 119.00
- 84.00